The paper highlights the candidate’s ability to target and shrink HPV motivated tumors in both animal studies and human blood samples.
HPV-Cancer Targeting Immunotherapy Enters Phase 1 Clinical Trial After Showing Success In Animals
The paper highlights the candidate’s ability to target and shrink HPV motivated tumors in both animal studies and human blood samples.